Homepage

About BioVax

The Government of Kenya has committed to build its own capacity for the production of human vaccines, as a long-term measure to ensure Kenya becomes self-sufficient in its vaccine needs and in building security of supply. The COVID-19 pandemic catalyzed the urgency for this initiative; hence, the Government has accelerated efforts towards this endeavour and gave a directive to venture into local production. As such Kenya Biovax Institute was incorporated whose mandate is to manufacture, package and commercialize specialized health products and technologies including vaccines, therapeutics and other biomedical products.

Manufacturing process will be approached through a phased implementation in order to navigate the challenges within the sector due to the complexity embedded in the production and manufacturing process, high technological and R&D ‘s barriers to entry, and the costs associated with vaccine production.

Vision

Innovate, Empower, Impact through production of quality human vaccines and therapuetics.

Mission

Innovate, develop, manufacture and commercialise vaccines and other specialised health technologies to improve access to quality health care.

Value Proposition

Pioneer vaccines and therapeutics manufature in East and Central Africa

Core Values

Innovation
Collaboration
Quality
Customer centric
Intergrity
Professionalist
Courage
Ressilience
Trust
Respect

Welcome to Biovax

Creative Concept Layouts

The Kenya Biovax Institute Limited’s mandate is to manufacture, package and commercialize specialized health products and technologies including vaccines, therapeutics and other biomedical products under the following objects, including but not limited to:

Manufacture of Human Vaccines, including COVID-19 vaccines, and such other routine and emergency vaccines to serve the people of Kenya and beyond;
Manufacture of other biomedical products including, among others, biosimilar anti-cancers, snake anti-venoms, insulin, medical infusions and such other biomedical products that can use the same platform as that of production of vaccines;
Manufacture of pharmaceutical diagnostics and Health Products and Technologies (HPTs) including Rapid test Diagnostic Test Kits, assistive devices and specialized HPTs for cancer and gene therapy;
Support technology transfer and commercialization of research outputs from research institutions, colleges and universities; and
Support local pharmaceutical industries in development and production of quality and affordable products.